(redirected from Lexapro)
Also found in: Medical.


A drug of the SSRI class, C22H21FN2O, that is a stereoisomer of citalopram and is given in the form of its oxalate to treat depression and anxiety.

[es-, isomer pref. (pronunciation spelling of the first letter of S-stereoisomer, isomer with counterclockwise rotation, from Latin sinister, left-handed; see sinister) + citalopram.]


n escitalopram m
Mentioned in ?
References in periodicals archive ?
Antidepressants sold in the United States that the study found to be most effective included: Amitriptyline Effexor (venlafaxine) Lexapro (escitalopram) Paxil (paroxetine) Remeron (mirtazapine) Trintellix (vortioxetine) Those that made the least-effective list of antidepressant drugs sold in the United States included: Luvox (fluvoxamine) Oleptro (trazodone) Prozac (fluoxetine)
Please consult with your doctor who is prescribing the Lexapro and make sure that it's ok that you're taking this.
After opening up about her OCD, Seyfried revealed she has been on the antidepressant drug, Lexapro, since she was 19 years old.
These findings suggest that SSRIs, which include Prozac, Zoloft, Paxil, Lexapro, and Effexor, may have a detrimental effect on bone health, although a cause-and-effect relationship has not been proven.
After checking over 200 pharmacies, the magazine found that the cost of a month's supply of Actos (Pioglitazone), Lexapro (Escitalopram), Lipitor (Atorvastatin), Plavix (Clopidogrel), and Singulair (Montelukast) "varied by as much as $749.
In March Lexapro lost its US patent and has since then faced generic competition.
All the women took the antidepressant Lexapro (escitalopram) during the trial.
The journey she embarks on reveals to her how dangerous the drug Lexapro, and other antidepressant medications, can be.
Esci-talopram initially was approved in 2002 and is marketed as Lexapro by Forest Laboratories.
M2 PHARMA-March 15, 2012-Teva Pharmaceutical Industries Ltd unveils generic Lexapro in the US with 180 day marketing exclusivity(C)2012 M2 COMMUNICATIONS
975bn, due to higher sales of key products and a milestone payment linked to the Japanese launch of escitalopram, which is Lundbeck's antidepressant Lexapro.
Forest Laboratories' 2004 marketing plan for Lexapro said " bylined articles will allow us to fold Lexapro messages into articles developed by ( or ghostwritten for) thought leaders".